ChromoGenics AB announced that due to unexpected administrative reasons, the Board of Directors of the company has decided to postpone the publication of the year-end report for 2023 until March 8, 2024. Previously communicated date for submission of the report was on the February 20, 2024. Full data on the fourth quarter 2023 will be published in the year-end report.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.98 SEK | +0.81% | +1.84% | +42.57% |
May. 30 | Swedish Energy Agency Converts ChromoGenics' SEK48 Million Loan to Grant | MT |
May. 23 | ChromoGenics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.57% | 6.28M | |
+51.42% | 9.28B | |
+15.84% | 2.6B | |
+15.31% | 1.11B | |
+21.08% | 794M | |
+0.85% | 408M | |
+1.15% | 343M | |
+8.33% | 232M | |
+17.92% | 206M | |
+0.32% | 165M |
- Stock Market
- Equities
- CHRO Stock
- News ChromoGenics AB
- ChromoGenics AB Postpones Publication of the Year-End Report for 2023